Combining renal cell arrest and damage biomarkers to predict progressive AKI in patient with sepsis
BMC Nephrology Dec 19, 2021
Tao X, Chen C, Luo W, et al. - The most common trigger for AKI is sepsis and there are up to 40% of mild or moderate septic AKI that progress to more severe AKI, which is linked with significantly raised risk for death and later CKD/ESRD. Researchers aimed at determining the factors that may aid in early identification of high risk patients for AKI progression in patients with septic AKI.
In this multicenter cohort study, 433 patients were screened; of whom, 149 patients with sepsis and stage 1 or 2 AKI were enrolled.
Progressive AKI developed in 63 patients and subsequent death occurred during hospitalization in 49 patients.
For the progression of septic AKI, following were independent predictors: u[TIMP-2]*[IGFBP7], uKIM-1 and uIL-18; among these, u[TIMP-2]*[IGFBP7] showed the greatest AUC.
The performance of predicting septic AKI progression improved in correlation with applying combination of u[TIMP-2]*[IGFBP7] with uKIM-1.
u[TIMP-2]*[IGFBP7], alone or combined with uKIM-1/uIL-18, had superior value for risk reclassification over the clinical risk factor model alone both for AKI progression and AKI progression with subsequent death during hospitalization.
In patients with sepsis, combination of renal cell arrest and damage biomarkers allowed improvement in the prediction of AKI progression and improvement in risk reclassification over the clinical risk factors.
-
Exclusive Write-ups & Webinars by KOLs
-
Daily Quiz by specialty
-
Paid Market Research Surveys
-
Case discussions, News & Journals' summaries